Skip to main content
. 2017 Oct 6;4(2):132–141. doi: 10.1093/ehjqcco/qcx037

Figure 1.

Figure 1

Randomized controlled trials on PCSK9 inhibitors. Black diamond represents studies lacking desired outcomes; blue diamond represents studies using non-US-FDA-approved PCSK9 inhibitors; green diamond represents studies with overlapping population with OSLER 1 study; and maroon diamond represents studies with overlapping population with OSLER 2 study.